Healthcare

    Find healthcare stock picks across big pharma, medical devices, hospitals, and insurers. Sector plays and watchlists for self-directed US investors.

    No posts in this category yet.

    Healthcare Stocks: Pharma, Devices, Hospitals, and Insurers

    Healthcare is the second-largest US equity sector and one of the most internally diverse. Big pharma, medical devices, hospitals, health insurers, and biotech each respond to different drivers, from drug approvals to reimbursement rules to demographic trends. Self-directed investors who treat "healthcare" as a single trade miss the rotation that happens within the sector every few months. Healthcare represents roughly 12% of the S&P 500 by market capitalization and includes some of the largest dividend payers in the index.

    The aging US population creates structural tailwinds across most healthcare sub-sectors that will compound for decades.

    Key Points

    • Healthcare stocks span six sub-sectors: big pharma, biotech (covered separately), medical devices, hospitals and providers, health insurers, and healthcare REITs.
    • The largest US-listed healthcare companies include Eli Lilly, Johnson and Johnson, UnitedHealth Group, Merck, AbbVie, and Pfizer.
    • Healthcare ETFs offer diversified exposure to the sector, smoothing single-name regulatory and clinical risk.

    What Healthcare Stocks Are

    Healthcare stocks are publicly traded companies that operate in the broader healthcare value chain. The category includes pharmaceutical companies (Eli Lilly, Pfizer, Merck, AbbVie, Bristol Myers Squibb), biotech (covered in our Biotech category), medical device companies (Medtronic, Stryker, Boston Scientific, Edwards Lifesciences), hospitals and care providers (HCA Healthcare, Tenet Healthcare, DaVita), health insurers and managed care (UnitedHealth, Elevance Health, Humana, Cigna, CVS Health), healthcare REITs (covered in our Real Estate category), and healthcare services (laboratory testing, drug distribution, contract research).

    GLP-1 stocks (covered separately) overlap with healthcare but are a specific sub-trend within obesity and diabetes treatments.

    How to Invest in Healthcare Stocks

    There are six main entry points.

    Big pharma combines dividend support with diversified pipelines. Eli Lilly (LLY) is the largest by market cap, dominant in GLP-1 drugs. Johnson and Johnson (JNJ) has 64 consecutive dividend raises. Pfizer (PFE) yields 6.5%. Merck (MRK), AbbVie (ABBV), and Bristol Myers Squibb (BMY) round out the major pharma names.

    Medical devices offer steady cash flow with less binary catalyst risk than pharma. Medtronic (MDT) is the largest US-listed pure medical device maker. Stryker (SYK), Boston Scientific (BSX), Edwards Lifesciences (EW), and Intuitive Surgical (ISRG) cover orthopedics, cardiovascular, and surgical robotics.

    Hospitals and providers offer cyclical exposure tied to hospital admissions and elective procedures. HCA Healthcare (HCA) is the largest US hospital operator. Tenet Healthcare (THC) and Universal Health Services (UHS) are smaller. Care providers include DaVita (DVA, dialysis) and Encompass Health (EHC, rehabilitation).

    Health insurers earn through premiums, with risk concentrated in medical loss ratios. UnitedHealth Group (UNH) is the largest US health insurer. Elevance Health (ELV, formerly Anthem), Humana (HUM), Cigna (CI), and CVS Health (CVS, owns Aetna) cover the major segments.

    Healthcare services and distribution include drug distributors (McKesson MCK, Cardinal Health CAH, Cencora COR), laboratories (Quest Diagnostics DGX, LabCorp LH), and contract research organizations (IQVIA IQV, Charles River CRL).

    Healthcare ETFs include the Health Care Select Sector SPDR Fund (XLV, the largest healthcare ETF), the Vanguard Health Care ETF (VHT), the iShares US Healthcare ETF (IYH), and various sub-sector ETFs (IHI for medical devices, IBB for biotech, IHF for healthcare providers).

    What to Consider

    Reimbursement and policy drive healthcare. Medicare, Medicaid, and private insurance reimbursement decisions affect every sub-sector.

    Drug pricing pressure is real. The Inflation Reduction Act's Medicare drug price negotiation has begun affecting major pharma names, with selected drugs facing negotiated price reductions on a rolling basis.

    Demographic tailwinds are durable. The aging US population supports long-term growth across most healthcare sub-sectors, especially medical devices and senior care.

    Earnings predictability varies. Pharma faces patent cliffs and trial outcomes. Insurance faces medical loss ratio swings. Hospitals face labor cost pressures. Each sub-sector has different earnings stability.

    Major Healthcare Sub-Sectors

    Big Pharma: LLY, JNJ, PFE, MRK, ABBV, BMY.

    Medical Devices: MDT, SYK, BSX, EW, ISRG, ABT.

    Hospitals and Providers: HCA, THC, UHS, DVA, EHC.

    Health Insurers: UNH, ELV, HUM, CI, CVS.

    Healthcare Services and Distribution: MCK, CAH, COR, DGX, LH, IQV.

    Healthcare REITs: VTR, HCP (covered in Real Estate).

    Healthcare ETFs: XLV, VHT, IYH, IHI, IHF.

    Market Outlook

    Healthcare sector earnings growth has been steady, supported by demographic tailwinds and continued innovation. The largest near-term swings in the sector come from major pharma earnings (Eli Lilly's GLP-1 results) and health insurer earnings (medical loss ratio surprises).

    Drug pricing remains a long-term overhang for major pharma. The Inflation Reduction Act's price negotiation continues to expand the list of covered drugs, with selected medications facing price reductions over multi-year periods.

    Medical devices have benefited from elective procedure volume growth as patient demand has normalized following pandemic-era disruptions. Surgical robotics, structural heart, and continuous glucose monitors are among the fastest-growing sub-segments, often growing at double-digit annual rates.

    Health insurer margins are sensitive to medical loss ratios. Periods of higher utilization can compress margins and rerate the group downward, while periods of stable utilization support multiple expansion.

    Frequently Asked Questions

    What are the best healthcare stocks to buy?

    The most-held US healthcare stocks among institutional investors include Eli Lilly, Johnson and Johnson, UnitedHealth Group, Merck, and AbbVie. Higher-growth exposure includes medical device leaders like Intuitive Surgical, Stryker, and Edwards Lifesciences. For diversified exposure, the Health Care Select Sector SPDR Fund (XLV) is the largest healthcare ETF.

    What is the largest healthcare company?

    By market capitalization, Eli Lilly and Johnson and Johnson trade as the largest US-listed healthcare stocks. UnitedHealth Group is the largest by revenue. By prescription drug sales, Eli Lilly leads, driven primarily by GLP-1 sales.

    What are medical device stocks?

    Medical device stocks include companies that manufacture medical equipment, implants, and diagnostic devices. The largest US-listed medical device stocks include Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, and Intuitive Surgical. Medical devices typically offer steadier cash flow than pharma with less binary trial risk.

    Why is UnitedHealth so large?

    UnitedHealth Group operates the largest health insurance business in the US (UnitedHealthcare), the largest pharmacy benefit manager (Optum Rx), one of the largest healthcare services businesses (Optum Health), and a healthcare data and analytics business. Combined, these segments produce annual revenue exceeding $400 billion.

    What is the best healthcare ETF?

    The Health Care Select Sector SPDR Fund (XLV) is the largest healthcare-focused ETF. The Vanguard Health Care ETF (VHT) is similar with slightly different weights. Sub-sector ETFs include the iShares US Medical Devices ETF (IHI), iShares Biotechnology ETF (IBB), and iShares US Healthcare Providers ETF (IHF).

    The Bottom Line

    Healthcare combines durable demographic tailwinds with the broadest sub-sector diversity in the US equity market. Coverage is built for self-directed US investors holding healthcare alongside other sectors and wanting sharper signal on rotation, dividends, and binary catalysts. For specific picks, see our Best Healthcare Stocks and Best Pharma Stocks guides.